title: Anticoagulation therapy. Dabigatran and risk of myocardial infarction.
abstract: Dabigatran has been associated with an increase in acute coronary events when compared with warfarin in several randomized trials, and now in a meta-analysis by Uchino and Hernandez. We critically review the evidence for this association and consider the implications for patient care.
authors.affiliation: Thrombosis and Atherosclerosis Research Institute, McMaster University, 237 Barton Street East, Hamilton, Ontario, Canada.
authors.forename: John W
authors.initials: JW
authors.lastname: Eikelboom
authors.forename: Jeffrey I
authors.initials: JI
authors.lastname: Weitz
mesh_terms: D054058:Acute Coronary Syndrome / Q000139:chemically induced*; D001562:Benzimidazoles / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000139:chemically induced*; D013923:Thromboembolism / Q000517:prevention & control*; D015091:beta-Alanine / Q000031:analogs & derivatives*
chemical_list: D001562:Benzimidazoles; D015091:beta-Alanine